Selected article for: "clinical response and study aim"

Title: 2017 ACVIM Forum Research Abstract Program
  • Document date: 2017_6_15
  • ID: ri2w5iby_207
    Snippet: Based on this proof of target study, further investigation is warranted to determine clinical response of TCC to Palladia. Chemotherapy-induced vomiting and inappetence (CIVI) are common adverse events experienced by cancer patients. However the incidence and recommended treatment following administration of specific chemotherapeutics has not been established in dogs. The aim of this study was to assess perceived emetogenic and inappetence potent.....
    Document: Based on this proof of target study, further investigation is warranted to determine clinical response of TCC to Palladia. Chemotherapy-induced vomiting and inappetence (CIVI) are common adverse events experienced by cancer patients. However the incidence and recommended treatment following administration of specific chemotherapeutics has not been established in dogs. The aim of this study was to assess perceived emetogenic and inappetence potential of chemotherapeutics and evaluate the clinical use of antiemetics and appetite stimulants in dogs receiving chemotherapy.

    Search related documents:
    Co phrase search for related documents